• 2022
  Arauna LR, Bergstedt J, Choin J, Mendoza-Revilla J, Harmant C, Roux M, Mas-Sandoval A, Lémée L, Colleran H, François A, Valentin F, Cassar O, Gessain A, Quintana-Murci L, Patin E, , The genomic landscape of contemporary western Remote Oceanians., Curr Biol 2022 Sep; (): .
• 2022
  Ramassamy JL, Ndongo CB, Nnuka P, Antunes M, Mener ML, A Betsem EB, Njouom R, Cassar O, Fontanet A, Gessain A, , Epidemiological evidence of nosocomial and zoonotic transmission of HTLV-1 in a large survey in rural population of central Africa., J Infect Dis 2022 Jul; (): .
• 2021
  Choin J, Mendoza-Revilla J, Arauna LR, Cuadros-Espinoza S, Cassar O, Larena M, Ko AM, Harmant C, Laurent R, Verdu P, Laval G, Boland A, Olaso R, Deleuze JF, Valentin F, Ko YC, Jakobsson M, Gessain A, Excoffier L, Stoneking M, Patin E, Quintana-Murci L, , Genomic insights into population history and biological adaptation in Oceania., Nature 2021 Apr; 592(7855): 583-589.
• 2021
  Mamimandjiami AI, Mouinga-Ondémé A, Ramassamy JL, Djuicy DD, Afonso PV, Mahé A, Lekana-Douki JB, Cassar O, Gessain A, , Epidemiology and Genetic Variability of HHV-8/KSHV among Rural Populations and Kaposi’s Sarcoma Patients in Gabon, Central Africa. Review of the Geographical Distribution of HHV-8 K1 Genotypes in Africa., Viruses 2021 Jan; 13(2): .
• 2020
  Cassar O, Desrames A, Marçais A, Gout O, Taylor GP, Hermine O, Soriano V, Mendoza C, Dehan O, Mener ML, Afonso PV, Gessain A, , Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains., Emerg Microbes Infect 2020 Dec; 9(1): 913-923.
• 2020
  Ramassamy JL, Cassar O, Toumbiri M, Diané A, Idam Mamimandjiami A, Bengone C, Ntsame-Ndong JM, Mouinga-Ondémé A, Gessain A, , High prevalence of human T-cell leukemia virus type-1b genotype among blood donors in Gabon, Central Africa., Transfusion 2020 May; (): .
• 2019
  Afonso PV, Cassar O, Gessain A, , Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes., Retrovirology 2019 12; 16(1): 39.
• 2019
  Vermeulen M, Sykes W, Coleman C, Custer B, Jacobs G, Jaza J, Kaidarova Z, Hlela C, Gessain A, Cassar O, Poole C, Ingram C, Murphy EL, Reddy R, , The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors., Vox Sang 2019 Jul; 114(5): 451-458.
• 2018
  Djuicy DD, Mouinga-Ondémé A, Cassar O, Ramassamy JL, Idam Mamimandjiami A, Bikangui R, Fontanet A, Gessain A, , Risk factors for HTLV-1 infection in Central Africa: A rural population-based survey in Gabon., PLoS Negl Trop Dis 2018 10; 12(10): e0006832.
• 2017
  Jackson CC, Lefèvre-Utile A, Guimier A, Malan V, Bruneau J, Gessain A, Cassar O, Amiel J, Cobat A, Rattina V, Abel L, Casanova JL, Blanche S, Kaposi sarcoma, oral malformations, mitral dysplasia, and scoliosis associated with 7q34-q36.3 heterozygous terminal deletion, Am. J. Med. Genet. A 2017 May;.
• 2017
  Oksenhendler E, Turpin J, Lhote R, Cassar O, Cayuela JM, Fieschi C, Galicier L, Meignin V, Bangham C, Gessain A, Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion, Int. J. Hematol. 2017 Jun;105(6):859-862.
• 2017
  Cassar O, Charavay F, Touzain F, Jeannin P, Grangeon JP, Laumond S, Chungue E, Martin PM, Gessain A, A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia, PLoS Negl Trop Dis 2017 Jan;11(1):e0005278.
• 2017
  Cassar O, Gessain A, Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection, Methods Mol. Biol. 2017;1582:3-24.
• 2016
  Einsiedel L, Woodman RJ, Flynn M, Wilson K, Cassar O, Gessain A, Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study, BMC Public Health 2016 08;16:787.
• 2016
  Einsiedel L, Cassar O, Spelman T, Joseph S, Gessain A, Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population, J. Clin. Virol. 2016 May;78:93-8.
• 2016
  Hogan CA, Iles J, Frost EH, Giroux G, Cassar O, Gessain A, Dion MJ, Ilunga V, Rambaut A, Yengo-Ki-Ngimbi AÉ, Behets F, Pybus OG, Pépin J, Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa, J. Infect. Dis. 2016 Aug;214(3):353-60.
• 2015
  Sibon D, Cassar O, Duga I, Brouzes C, Ghez D, Pasquier C, Sibon C, Desrames A, Mortreux F, Wattel E, Bazarbachi A, Gessain A, Hermine O, Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1, Open Forum Infect Dis 2015 Apr;2(2):ofv032.
• 2015
  Filippone C, Betsem E, Tortevoye P, Cassar O, Bassot S, Froment A, Fontanet A, Gessain A, A Severe Bite From a Nonhuman Primate Is a Major Risk Factor for HTLV-1 Infection in Hunters From Central Africa, Clin. Infect. Dis. 2015 Jun;60(11):1667-76.
• 2014
  Desrames A, Cassar O, Gout O, Hermine O, Taylor GP, Afonso PV, Gessain A, Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event, J. Virol. 2014 Sep;88(17):9782-8.
• 2014
  Einsiedel L, Cassar O, Goeman E, Spelman T, Au V, Hatami S, Joseph S, Gessain A, Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study, Open Forum Infect Dis 2014 Mar;1(1):ofu023.
• 2014
  Betsem E, Cassar O, Afonso PV, Fontanet A, Froment A, Gessain A, Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon, PLoS Negl Trop Dis 2014 May;8(5):e2851.
• 2014
  Martel-Jantin C, Filippone C, Tortevoye P, Afonso PV, Betsem E, Descorps-Declere S, Nicol JT, Touzé A, Coursaget P, Crouzat M, Berthet N, Cassar O, Gessain A, Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes, J. Clin. Microbiol. 2014 May;52(5):1687-90.
• 2014
  Einsiedel L, Spelman T, Goeman E, Cassar O, Arundell M, Gessain A, Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population, PLoS Negl Trop Dis 2014;8(1):e2643.
• 2013
  Einsiedel L, Cassar O, Bardy P, Kearney D, Gessain A, Variant human T-cell lymphotropic virus type 1c and adult T-cell leukemia, Australia, Emerging Infect. Dis. 2013 Oct;19(10):1639-41.
• 2013
  Cassar O, Einsiedel L, Afonso PV, Gessain A, Human T-cell lymphotropic virus type 1 subtype C molecular variants among indigenous australians: new insights into the molecular epidemiology of HTLV-1 in Australo-Melanesia, PLoS Negl Trop Dis 2013;7(9):e2418.
• 2013
  Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, Canpolat N, Aydogan G, Fleckenstein B, Bustamante J, Picard C, Gessain A, Jouanguy E, Cesarman E, Olivier M, Gros P, Abel L, Croft M, Tangye SG, Casanova JL, Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood, J. Exp. Med. 2013 Aug;210(9):1743-59.
• 2013
  Einsiedel L, Cassar O, Gordon L, Gessain A, Human T-lymphotropic virus type 1 infective dermatitis in central Australia, J. Clin. Virol. 2013 Aug;57(4):370-3.
• 2013
  Desdouits M, Cassar O, Maisonobe T, Desrames A, Aouba A, Hermine O, Mikol J, Polivka M, Penisson-Besnier I, Marcorelles P, Zagnoli F, Papo T, Lacour A, Amoura Z, Haroche J, Cherin P, Teixeira A, Benveniste O, Herson S, Morin AS, Mortreux F, Wattel E, Huerre M, Cumont MC, Martin-Latil S, Butler-Browne G, Gout O, Taylor G, Gessain A, Ozden S, Ceccaldi PE, HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa, J. Clin. Virol. 2013 May;57(1):70-6.
• 2012
  Gessain A, Cassar O, Epidemiological Aspects and World Distribution of HTLV-1 Infection, Front Microbiol 2012;3:388.
• 2012
  Martel-Jantin C, Filippone C, Cassar O, Peter M, Tomasic G, Vielh P, Brière J, Petrella T, Aubriot-Lorton MH, Mortier L, Jouvion G, Sastre-Garau X, Robert C, Gessain A, Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma, Virology 2012 May;426(2):134-42.
• 2012
  Cassar O, Charavay F, Bassot S, Plancoulaine S, Grangeon JP, Laumond-Barny S, Martin PM, Chanteau S, Gessain A, Divergent KSHV/HHV-8 subtype D strains in New Caledonia and Solomon Islands, Melanesia, J. Clin. Virol. 2012 Mar;53(3):214-8.
• 2011
  Leroy S, Moshous D, Cassar O, Reguerre Y, Byun M, Pedergnana V, Canioni D, Gessain A, Oksenhendler E, Fieschi C, Mahlaoui N, Rivière JP, Herbigneaux RM, Muszlak M, Arnaud JP, Fischer A, Picard C, Blanche S, Plancoulaine S, Casanova JL, Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review, Pediatrics 2012 Jan;129(1):e199-203.
• 2010
  Brucato N, Cassar O, Tonasso L, Tortevoye P, Migot-Nabias F, Plancoulaine S, Guitard E, Larrouy G, Gessain A, Dugoujon JM, The imprint of the Slave Trade in an African American population: mitochondrial DNA, Y chromosome and HTLV-1 analysis in the Noir Marron of French Guiana, BMC Evol. Biol. 2010;10:314.
• 2010
  Cassar O, Blondot ML, Mohanna S, Jouvion G, Bravo F, Maco V, Duprez R, Huerre M, Gotuzzo E, Gessain A, Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru, Emerging Infect. Dis. 2010 Sep;16(9):1459-62.
• 2010
  Duval A, Rivet J, Moulonguet I, Cassar O, Agbalika F, Wallach D, Gessain A, Petit A, Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: prurigo nodularis lasting twelve years followed by an acute micropapular eruption, Acta Derm. Venereol. 2010 May;90(3):287-90.
• 2010
  Cassar O, Bassot S, Plancoulaine S, Quintana-Murci L, Harmant C, Gurtsevitch V, Senyuta NB, Yakovleva LS, de The G, Gessain A, Human herpesvirus 8, Southern Siberia, Emerging Infect. Dis. 2010 Mar;16(3):580-2.
• 2010
  Sahin G, Palanduz A, Aydogan G, Cassar O, Ertem AU, Telhan L, Canpolat N, Jouanguy E, Picard C, Gessain A, Abel L, Casanova JL, Plancoulaine S, Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds, Pediatrics 2010 Mar;125(3):e704-8.
• 2009
  Moens B, López G, Adaui V, González E, Kerremans L, Clark D, Verdonck K, Gotuzzo E, Vanham G, Cassar O, Gessain A, Vandamme AM, Van Dooren S, , Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination., J Clin Microbiol 2009 Nov; 47(11): 3682-91.
• 2007
  Cassar O, Afonso PV, Bassot S, Plancoulaine S, Duprez R, Capuano C, Abel M, Martin PM, Gessain A, Novel human herpesvirus 8 subtype D strains in Vanuatu, Melanesia, Emerging Infect. Dis. 2007 Nov;13(11):1745-8.
• 2007
  Cassar O, Capuano C, Bassot S, Charavay F, Duprez R, Afonso PV, Abel M, Walter H, Mera W, Martin PM, Chungue E, Gessain A, Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor, J. Infect. Dis. 2007 Aug;196(4):510-21.
• 2006
  Roche C, Cassar O, Laille M, Murgue B, Dengue-3 virus genomic differences that correlate with in vitro phenotype on a human cell line but not with disease severity, Microbes Infect. 2007 Jan;9(1):63-9.
• 2006
  Duprez R, Cassar O, Hbid O, Rougier Y, Morisse L, Bassot S, Huerre M, Gessain A, Cutaneous disseminated endemic Kaposi’s sarcoma in a Polynesian man infected with a new divergent human herpesvirus 8 subtype D, J. Clin. Virol. 2006 Nov;37(3):222-6.
• 2006
  Verdu P, Barreiro LB, Patin E, Gessain A, Cassar O, Kidd JR, Kidd KK, Behar DM, Froment A, Heyer E, Sica L, Casanova JL, Abel L, Quintana-Murci L, Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles, Hum. Mol. Genet. 2006 Sep;15(17):2650-8.
• 2005
  Cassar O, Capuano C, Meertens L, Chungue E, Gessain A, Human T-cell leukemia virus type 1 molecular variants, Vanuatu, Melanesia, Emerging Infect. Dis. 2005 May;11(5):706-10.
• 2004
  Murgue B, Cassar O, Roche C, Deparis X, [Pathogenesis of dengue: the emperor is still naked], Med Mal Infect 2004 Jun;34 Suppl 1:S31-3.
• 2001
  Murgue B, Cassar O, Deparis X, Plasma concentrations of sVCAM-1 and severity of dengue infections, J. Med. Virol. 2001 Sep;65(1):97-104.
• 1999
  Murgue B, Deparis X, Chungue E, Cassar O, Roche C, Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases, Trop. Med. Int. Health 1999 Nov;4(11):765-73.
• 1998
  Laur F, Murgue B, Deparis X, Roche C, Cassar O, Chungue E, Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia, Trans. R. Soc. Trop. Med. Hyg. 1998 Nov-Dec;92(6):654-6.
• 1998
  Deparis X, Murgue B, Roche C, Cassar O, Chungue E, Changing clinical and biological manifestations of dengue during the dengue-2 epidemic in French Polynesia in 1996/97–description and analysis in a prospective study, Trop. Med. Int. Health 1998 Nov;3(11):859-65.
• 1998
  Murgue B, Cassar O, Deparis X, Guigon M, Chungue E, Implication of macrophage inflammatory protein-1alpha in the inhibition of human haematopoietic progenitor growth by dengue virus, J. Gen. Virol. 1998 Aug;79 ( Pt 8):1889-93.
• 1997
  Murgue B, Cassar O, Guigon M, Chungue E, Dengue virus inhibits human hematopoietic progenitor growth in vitro, J. Infect. Dis. 1997 Jun;175(6):1497-501.
• 1995
  Chungue E, Cassar O, Drouet MT, Guzman MG, Laille M, Rosen L, Deubel V, Molecular epidemiology of dengue-1 and dengue-4 viruses, J. Gen. Virol. 1995 Jul;76 ( Pt 7):1877-84.
• 1993
  Chungue E, Deubel V, Cassar O, Laille M, Martin PM, Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia, J. Gen. Virol. 1993 Dec;74 ( Pt 12):2765-70.